首页> 外文期刊>Turkish Journal of Hematology >Successful Treatment of Recurrent Gastrointestinal Bleeding due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide – Two Birds with One Stone
【24h】

Successful Treatment of Recurrent Gastrointestinal Bleeding due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide – Two Birds with One Stone

机译:由于小肠血管内血糖和多发性骨髓瘤与沙利度胺类的多发性胃癌的成功治疗 - 两只鸟

获取原文
           

摘要

Gastrointestinal angiodysplasia (GIA) is the most commondigestive tract vascular malformation, often causing recurrentgastrointestinal bleeding. Despite association with certainhereditary diseases [1,2,3], most GIAs are acquired, associatedwith aortic stenosis, hemodialysis, malignancies, or livercirrhosis or idiopathic, and they appear among the elderly (60years) [4]. Advances in endoscopy brought about managementimprovements, but due to numerous lesions disseminated overthe digestive tract, treatment of GIA remains a clinical challenge.Novel studies suggested that the use of thalidomide might bebeneficial in these patients due to its antiangiogenic properties[5,6]. Thalidomide and its modern analogues currently representa backbone treatment of another disease: multiple myeloma(MM) [7]. Here we would like to present a case of successful MMand GIA treatment with thalidomide.
机译:胃肠血管血管血管缺陷(GIA)是最宽容的血管血管畸形,常常导致复杂的报价出血。尽管与委员会疾病联系[1,2,3],但大多数胶质都是被获得的,与主动脉狭窄,血液透析,恶性肿瘤或性发育性相关,它们出现在老年人(> 60年)中[4]。内窥镜检查的进展带来了管理层的管理,但由于缺乏消化道的许多病变,GIA的治疗仍然是临床挑战。诺尔研究表明,由于其抗血管生成性能,在这些患者中可能缺乏氰化物的使用[5,6]。沙利度胺及其现代类似物目前代表了另一种疾病的骨干处理:多发性骨髓瘤(mm)[7]。在这里,我们想提出一种成功的Mmand Gia与沙利度胺治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号